Ahn Stephen, Han Kyungdo, Lee Jung-Eun, Jeun Sin-Soo, Park Yong-Moon, Yang Seung Ho
Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Department of Statistics and Actuarial Science, Soongsil University, Seoul 06978, Korea.
Cancers (Basel). 2021 Jun 8;13(12):2859. doi: 10.3390/cancers13122859.
The association between obesity and the risk of glioma remains unclear. We sought to evaluate the potential association between general and abdominal obesity and the risk of glioma based on a nationwide population-based cohort study of Koreans. Using data from the Korean National Health Insurance System cohort, 6,833,744 people older than 20 years who underwent regular national health examination in both 2009 and 2011 were followed until the end of 2017. We documented 4771 glioma cases based on an ICD-10 code of C71 during the median follow-up period of 7.30 years. Individuals with a body mass index (BMI) ≥ 25.0 kg/m were at significantly higher risk of developing glioma than those with a BMI < 25.0 kg/m (HR 1.08 CI 1.02-1.15). Individuals with a waist circumference (WC) ≥ 90 cm (males)/85 cm (females) also had a significantly higher risk of glioma than those with a WC < 90 cm (males)/85 cm (females) (HR 1.16 CI 1.09-1.24). In the group with a BMI ≥ 25.0 kg/m, individuals with abdominal obesity were at significantly higher risk of developing glioma (HR 1.18 CI 1.09-1.27) than those without abdominal obesity. The role of abdominal obesity in this association was stronger in women than in men. To the best of our knowledge, this is the first demonstration that obese people may be at higher risk of glioma, especially centrally obese people from an Asian population with a BMI ≥ 25.0 kg/m. Loss of visceral fat in people with abdominal obesity may reduce their risk of developing glioma.
肥胖与胶质瘤风险之间的关联仍不明确。我们试图基于一项针对韩国人的全国性人群队列研究,评估全身肥胖和腹型肥胖与胶质瘤风险之间的潜在关联。利用韩国国民健康保险系统队列的数据,对2009年和2011年接受定期全国健康检查的6833744名20岁以上的人进行随访,直至2017年底。在中位随访期7.30年期间,我们根据ICD - 10编码C71记录了4771例胶质瘤病例。体重指数(BMI)≥25.0kg/m²的个体患胶质瘤的风险显著高于BMI<25.0kg/m²的个体(风险比1.08,置信区间1.02 - 1.15)。腰围(WC)≥90cm(男性)/85cm(女性)的个体患胶质瘤的风险也显著高于WC<90cm(男性)/85cm(女性)的个体(风险比1.16,置信区间1.09 - 1.24)。在BMI≥25.0kg/m²的人群中,腹型肥胖个体患胶质瘤的风险(风险比1.18,置信区间1.09 - 1.27)显著高于非腹型肥胖个体。腹型肥胖在这种关联中的作用在女性中比在男性中更强。据我们所知,这是首次证明肥胖人群,尤其是BMI≥25.0kg/m²的亚洲腹型肥胖人群可能患胶质瘤的风险更高。腹型肥胖人群内脏脂肪的减少可能会降低他们患胶质瘤的风险。